Characteristics | n (%) |
---|---|
Gender | |
Male | 19 (50.0) |
Female | 19 (50.0) |
Age at diagnosis, median (range) | 4 (0-72) |
Age group | |
Up to 4 months | 20 (52.6) |
4-12 months | 14 (36.8) |
Over 12 months | 4 (10.5) |
Diagnosis | |
Qatar | 24 (63.1) |
Elsewhere | 14 (36.9) |
Family history | |
Yes | 10 (26.3) |
No | 28 (73.7) |
Genetic analysis | |
Mutation in TSC1 | 1 (2.6) |
Mutation in TSC2 | 33 (86.8) |
Genetic studies negative | 4 (10.5) |
Presentation | |
Infantile spasms | 14 (36.8) |
Seizures (other than infantile spasms) | 18 (47.3) |
Developmental delay | 5 (13.1) |
Cardiac rhabdomyoma | 8 (21.0) |
Hypopigmented spots | 5 (13.1) |
Major criteria for TSC | |
Hypomelanotic nodules | 29 (76.3) |
Angiofibroma | 20 (52.6) |
Ungual fibroma | 0 (0.0)) |
Shagreen patch | 7 (18.4) |
Retinal hamartoma | 5 (13.1) |
Cortical dysplasia | 29 (76.3) |
Subependymal nodules | 37 (97.3) |
SEGA | 10 (26.3) |
Cardiac rhabdomyoma | 16 (42.1) |
LAM | 0 (0.0) |
AML | 22 (57.8) |
Minor criteria for TSC | |
Confetti lesions | 4 (10.5) |
Dental enamel pits | 2 (5.3) |
Intra-oral fibroma | 2 (5.3) |
Retinal achromic patch | 0 (0.0) |
Multiple renal cysts | 29 (76.3) |
Non-renal hamartomas | 4 (10.5) |
Neuro-imaging features | |
Tubers | 37 (97.3) |
SEN | 37 (97.3) |
SEGA | 10 (26.3) |
Values are presented as numbers and percentages (%).
TSC: tuberous sclerosis complex, SEGA: subependymal giant cell astrocytoma, LAM: lymphangioleiomyomatosis, AML: angiomyolipoma, SEN: subependymal nodules